Emergent Biosolutions Inc. Stock
Emergent Biosolutions Inc. took a tumble today and lost -€0.191 (-3.840%).
Based on 2 Buy predictions and 3 Sell predictions the sentiment towards Emergent Biosolutions Inc. is rather balanced.
With a target price of 4 € there is a slightly negative potential of -14.88% for Emergent Biosolutions Inc. compared to the current price of 4.7 €.
Our community identified positive and negative aspects for Emergent Biosolutions Inc. stock for the coming years. 1 users see the criterium "Company culture" as a plus for the Emergent Biosolutions Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Emergent Biosolutions Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Emergent Biosolutions Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. | -3.840% | 14.470% | 142.029% | -44.423% | 110.907% | -90.801% | -88.426% |
Ironwood Pharmaceuticals | -5.560% | -20.134% | -19.595% | -36.022% | -41.667% | -37.696% | - |
Sage Therapeutics Inc. | 1.170% | -8.375% | -23.950% | -77.075% | -44.750% | -81.939% | - |
Novocure Ltd | -0.400% | 30.135% | 47.160% | -72.830% | 31.594% | -87.273% | - |
Comments
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co..
Show more
Ratings data for EBS provided by MarketBeat